Ian F. Smith, EVP, COO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,125 shares at $155.03 ($331K) on 2017-10-16, disclosed to the SEC on 2017-10-18.
Scheduled sale ($331k) by EVP, COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $154.01 | 200 | $31K | 9.3% |
| 2 | $155.03 | 875 | $136K | 41.0% |
| 3 | $156.24 | 850 | $133K | 40.2% |
| 4 | $157.07 | 200 | $31K | 9.5% |
| Total | $155.61 avg | 2,125 | $331K | 100% |
| Filing → |
| ACOR | SELL | 2018-06-19 | $786K | — | Filing → |
| VRTX | SELL | 2018-05-16 | $34K | — | Filing → |
| VRTX | SELL | 2018-05-15 | $635K | — | Filing → |